171 related articles for article (PubMed ID: 20200189)
1. Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein.
Breiman A; Smith GL
J Gen Virol; 2010 Jul; 91(Pt 7):1823-7. PubMed ID: 20200189
[TBL] [Abstract][Full Text] [Related]
2. Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein.
Breiman A; Carpentier DCJ; Ewles HA; Smith GL
J Gen Virol; 2013 Apr; 94(Pt 4):720-725. PubMed ID: 23255618
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia Virus Glycoproteins A33, A34, and B5 Form a Complex for Efficient Endoplasmic Reticulum to
Monticelli SR; Earley AK; Stone R; Norbury CC; Ward BM
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941777
[TBL] [Abstract][Full Text] [Related]
4. Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
Roberts KL; Breiman A; Carter GC; Ewles HA; Hollinshead M; Law M; Smith GL
J Gen Virol; 2009 Jul; 90(Pt 7):1582-1591. PubMed ID: 19264647
[TBL] [Abstract][Full Text] [Related]
5. The Ectodomain of the Vaccinia Virus Glycoprotein A34 Is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with Glycoprotein B5.
Monticelli SR; Earley AK; Tate J; Ward BM
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463966
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.
Perdiguero B; Lorenzo MM; Blasco R
J Virol; 2008 Mar; 82(5):2150-60. PubMed ID: 18094186
[TBL] [Abstract][Full Text] [Related]
7. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.
Perdiguero B; Blasco R
J Virol; 2006 Sep; 80(17):8763-77. PubMed ID: 16912323
[TBL] [Abstract][Full Text] [Related]
8. Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
Doceul V; Hollinshead M; Breiman A; Laval K; Smith GL
J Gen Virol; 2012 Sep; 93(Pt 9):1876-1886. PubMed ID: 22622330
[TBL] [Abstract][Full Text] [Related]
9. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.
Earley AK; Chan WM; Ward BM
J Virol; 2008 Mar; 82(5):2161-9. PubMed ID: 18094183
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5.
Lorenzo MM; Sánchez-Puig JM; Blasco R
J Gen Virol; 2012 Apr; 93(Pt 4):733-743. PubMed ID: 22238237
[TBL] [Abstract][Full Text] [Related]
11. The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.
Chan WM; Ward BM
J Virol; 2012 Aug; 86(15):8210-20. PubMed ID: 22623777
[TBL] [Abstract][Full Text] [Related]
12. Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.
Chan WM; Ward BM
J Virol; 2012 Aug; 86(15):8232-44. PubMed ID: 22623782
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
McIntosh AA; Smith GL
J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
Wolffe EJ; Isaacs SN; Moss B
J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
[TBL] [Abstract][Full Text] [Related]
15. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
Katz E; Wolffe EJ; Moss B
J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus morphogenesis and dissemination.
Roberts KL; Smith GL
Trends Microbiol; 2008 Oct; 16(10):472-9. PubMed ID: 18789694
[TBL] [Abstract][Full Text] [Related]
17. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
Smith GL; Vanderplasschen A
Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
[TBL] [Abstract][Full Text] [Related]
18. An investigation of incorporation of cellular antigens into vaccinia virus particles.
Krauss O; Hollinshead R; Hollinshead M; Smith GL
J Gen Virol; 2002 Oct; 83(Pt 10):2347-2359. PubMed ID: 12237415
[TBL] [Abstract][Full Text] [Related]
19. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
Lorenzo MM; Herrera E; Blasco R; Isaacs SN
Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
